About Harmosan Pharma
Harmosan Pharma was founded in 1968 in Frankfurt Am Main, Germany, and operates within the energy sector. Electricity generation is conducted alongside the management of a gas drying plant. Services encompass energy production processes, including customer inquiry handling and adherence to regulatory standards. Operations focus on these core activities to support regional energy needs.
- Headquarter Frankfurt Am Main, Germany
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Harmosan Pharma
Investors in Harmosan Pharma
Harmosan Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lupin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical products including generics, biosimilars, and APIs are manufactured.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Harmosan Pharma
Financial Statements - Harmosan Pharma
Harmosan Pharma Comparisons
Competitors of Harmosan Pharma
Latest news on Harmosan Pharma
Frequently Asked Questions about Harmosan Pharma
Harmosan Pharma was founded in 1968.
Harmosan Pharma is headquartered in Frankfurt Am Main, Germany. It is registered at Frankfurt Am Main, Hesse, Germany.
Werner Schneider is the current CEO of Harmosan Pharma.
Harmosan Pharma was founded in 1968 in Frankfurt Am Main, Germany, and operates within the energy sector. Electricity generation is conducted alongside the management of a gas drying plant. Services encompass energy production processes, including customer inquiry handling and adherence to regulatory standards. Operations focus on these core activities to support regional energy needs.
Harmosan Pharma has 1 investor. Key investors include Lupin.